PPCB
Price:
$0.99
Market Cap:
$865.63K
Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officiall...[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
NASDAQ
Ticker
PPCB
According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -89.56% compared to the average of -1.15 of the last 4 quarters.
The mean historical PE Ratio of Propanc Biopharma, Inc. over the last ten years is -1947916586.93. The current -0.12 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), PPCB's PE Ratio was at its highest in in the June 2020 quarter at 0.42. The PE Ratio was at its lowest in in the September 2016 quarter at -47916664888.89.
Average
-1947916586.93
Median
-0.27
Minimum
-19479165866.67
Maximum
-0.00
Discovering the peaks and valleys of Propanc Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.92%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -19479165866.67
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.28 | 409.10% |
| 2024 | -0.05 | -78.81% |
| 2023 | -0.26 | 3.92% |
| 2022 | -0.00 | -99.99% |
| 2021 | -0.13 | 218.90% |
| 2020 | -0.04 | -93.83% |
| 2019 | -0.66 | 113.32% |
| 2018 | -0.31 | -64.45% |
| 2017 | -0.87 | -100.00% |
| 2016 | -19479165866.67 | -79.20% |
The current PE Ratio of Propanc Biopharma, Inc. (PPCB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.20
5-year avg
-0.14
10-year avg
-1947916586.93
Propanc Biopharma, Inc.’s PE Ratio is less than Quest PharmaTech Inc. (0.98), greater than Gemina Laboratories Ltd. (-1.54), greater than Telescope Innovations Corp. (-7.43), greater than PreveCeutical Medical Inc. (-5.00), greater than Synairgen plc (-0.23), greater than EOM Pharmaceuticals Holdings, Inc. (-8.55), greater than Cell Source, Inc. (-8.23), greater than Zenith Capital Corp. (-1.03), greater than HOOKIPA Pharma Inc. (-0.71), greater than Sirona Biochem Corp. (-0.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0.98 | $3.38M | |
| -1.54 | $3.83M | |
| -7.43 | $23.80M | |
| -5.00 | $7.66M | |
| -0.23 | $110.27K | |
| -8.55 | $16.45M | |
| -8.23 | $37.08M | |
| -1.03 | $7.99M | |
| -0.71 | $14.40M | |
| -0.71 | $1.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Propanc Biopharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Propanc Biopharma, Inc. (PPCB)?
What is the highest PE Ratio for Propanc Biopharma, Inc. (PPCB)?
What is the 3-year average PE Ratio for Propanc Biopharma, Inc. (PPCB)?
What is the 5-year average PE Ratio for Propanc Biopharma, Inc. (PPCB)?
How does the current PE Ratio for Propanc Biopharma, Inc. (PPCB) compare to its historical average?